Organ Preservation Market Top Companies and Trends by Types and Application | Forecast Analysis To 2023
Presently, the study depicts that the “Organ Preservation Market is anticipated to capture a healthy position by 2023, as it will surge at a CAGR of 8%”. The need to optimize services related to organs transplantation, organ failures, and more is the leading cause for the market to inflate during the forecast period.
Market Overview
The global organ preservation market is mainly driven by
the high incidences of organ failures, increasing advancements in surgeries,
increasing procedures of organ transplantation, and growing patient population
with organ failure cases. The need for efficient treatment for organs is
motivating the growth of the market at an exceptional pace. The expansion of
the market is based to a great extent on developments such in the medical
sector, which is expected to be the driving force for the global organ
preservation market over the assessment period.
Request a FREE Sample Copy at https://www.marketresearchfuture.com/sample_request/6073
The market players are also to play a pivotal role in
capitalizing the global organ preservation market with the help of more
research & development activities, more collaborations with foreign medical
institutes and medical R&D centers to bring more opportunities for patients
for surgeries. In the forecast period, the improvements in the concepts of
organ preservation are expected to accelerate the evolution of the global organ
preservation market.
Market Players
some of the active players contributing to the market
growth of Organ Preservation Market are,
- Bristol-Myers Squibb
- Xvivo Perfusion AB
- Essential Pharmaceuticals LLC
- Franz Kohler Chemie GmbH
- BioLife Solutions Inc.
- Bristol-Myers Squibb
- Claris Lifesciences Limited
- Lifeline Scientific
- ToleroTech Inc.
- 21st Century Medicine
- CryoLife Inc
Some factors such as high cost of organ preservation and
its complicated transplantation procedures, along with the unavailability of
the suitable donor and development of organs by stem cell therapy could be a
hinder to the growth of the market in the forecast period.
Market Segmentation
Globally, the organ preservation market has been
categorized among various segments, which include such as preservation
solution, organ type, the technique of preservation, and end-user.
By preservation solution:
perfadex, University of Wisconsin (UW) solution, custodiol HTK, celsior
solution, citrate solutions, and Collins solution are the segments.
By organ type: liver,
kidney, heart, lungs, and others are the segments.
By the technique of preservation: Static cold storage and dynamic cold storage are the segments,
where dynamic cold storage is extra segmented into hypothermic machine
perfusion, normothermic machine perfusion, and oxygen persufflation.
By end-user: organ banks,
hospitals and clinics, and others are the segments.
Access Full Detailed Copy of This Report at https://www.marketresearchfuture.com/reports/organ-preservation-market-6073
Regional Outlook
The region-based analysis of the global organ preservation
market covers the regions of the Americas, Europe, Asia Pacific, and the Middle
East and Africa.
Among these, Americas control the largest market share for
organ preservation from 2018–2023. The adoption of technological advancements
with the increasing prevalence of cardiovascular disease and rising elder
population leading to organ failure are motivating the growth of the market.
Additionally, the increasing initiative by the U.S. government with
reimbursement policies in advanced treatment options are also driving the
market to surge considerably. According to the American Heart Association, in
2014, about 31% of the deaths in the U.S. were caused by cardiovascular
disorders. As per, the National Chronic Kidney Disease report, 2017, chronic
kidney diseases are common among adults in the U.S. and 30 million people, or
15% of the U.S. adults are probable to suffer chronic kidney disease. Such a
growing rate of cardiovascular disorders are expected to affect organ
preservation market directly.
The European market is expected to demonstrate a large
portion of the market share in support of the availability of advanced
treatment facilities, healthcare expenditure, and rising cases of the alcoholic
fatty liver disease lead to liver failure. Also, various government legislative
reforms are providing regulatory guidelines to manufacturing companies to
flourish medical device, which will eventually drive the European market.
Rising elder population is also eventually supplementing the growth of the
organ preservation market.
Apart from them, Asia Pacific is also expected to be the
fastest growing market because of the increasing prevalence of chronic
diseases, which is acting as a significant driver of market growth. China is
one of the foremost countries which has been one of the fastest countries with
a swelling population and raising awareness about health and accessibility of
new treatment methods. Rising healthcare expenditure and rise in the Asia Pacific
region is supplementing the growth of the organ preservation market. Whereas,
the Middle East & Africa is also expected to portray the least growth in
the market due to some significant factors such as lack of awareness, limited
access and unaffordability of treatment facilities in middle-income countries.
In the Middle East, the United Arab Emirates has spotted to be the largest
market share due to the development of the healthcare industry and the
increasing availability of specialty care centers.
Ask for an Amazing Discount at https://www.marketresearchfuture.com/check-discount/6073
About US: Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment